Related references
Note: Only part of the references are listed.The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
Osagie A. Eribo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naive Crohn's Disease: A Case Series
Gaurav Agrawal et al.
MICROORGANISMS (2020)
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
The Safety of Fecal Microbiota Transplantation for Crohn's Disease: Findings from A Long-Term Study
Honggang Wang et al.
ADVANCES IN THERAPY (2018)
Late breaking abstracts Abstracts
[Anonymous]
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
TNFα inhibitors exacerbate Mycobacterium paratuberculosis infection in tissue culture: a rationale for poor response of patients with Crohn's disease to current approved therapy
Ahmad Qasem et al.
BMJ OPEN GASTROENTEROLOGY (2018)
Market share and costs of biologic therapies for inflammatory bowel disease in the USA
H. Yu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Diet and microbiota in inflammatory bowel disease: The gut in disharmony
Davy C. M. Rapozo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Resolution of Crohn's (Johne's) disease with antibiotics: what are the next steps?
William C. Davis et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Dysbiosis of the Fecal Microbiota in Cattle Infected with Mycobacterium avium subsp paratuberculosis
Marie-Eve Fecteau et al.
PLOS ONE (2016)
Mycobacterium avium Subspecies paratuberculosis Infection Modifies Gut Microbiota under Different Dietary Conditions in a Rabbit Model
Rakel Arrazuria et al.
FRONTIERS IN MICROBIOLOGY (2016)
Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: Safety, feasibility, and efficacy trial results
Bota Cui et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease
Warren Strober et al.
IMMUNOLOGICAL REVIEWS (2014)
Is Crohn's Disease Ready for Fecal Microbiota Transplantation?
Thomas J. Borody et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Mucosal healing and deep remission: What does it mean?
Gerhard Rogler et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
Paul Rutgeerts et al.
GASTROENTEROLOGY (2012)
Polymorphisms of NOD2 and the risk of tuberculosis: a validation study in the Chinese population
H. Pan et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2012)
Treatment of Crohn's disease patients with infliximab is detrimental for the survival of Mycobacterium avium ssp paratuberculosis within macrophages and shows a remarkable decrease in the immunogenicity of mycobacterial proteins
Horacio Bach et al.
JOURNAL OF CROHNS & COLITIS (2012)
Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab
D. Laharie et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Primary treatment of Crohn's disease: combined antibiotics taking center stage
William Chamberlin et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2011)
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives
Marie Joossens et al.
GUT (2011)
Robert Koch and the 'golden age' of bacteriology
Steve M. Blevins et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Andre Franke et al.
NATURE GENETICS (2010)
Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2009)
Comparison of three methods for susceptibility testing of Mycobacterium avium subsp paratuberculosis to 11 antimicrobial drugs
Manju Y. Krishnan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Effects of interactions of antibacterial drugs with each other and with 6-mercaptopurine on in vitro growth of Mycobacterium avium subspecies paratuberculosis
Manju Y. Krishnan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: A systematic review and meta-analysis
I. Abubakar et al.
INFLAMMATORY BOWEL DISEASES (2008)
Animycobacterial therapy for Crohn's disease: a reanalysis
Marcel A. Behr et al.
LANCET INFECTIOUS DISEASES (2008)
On the Action of Cyclosporine A, Rapamycin and Tacrolimus on M. avium Including Subspecies paratuberculosis
Robert J. Greenstein et al.
PLOS ONE (2008)
Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease
Daniel R. Beckler et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
On the Action of 5-Amino-Salicylic Acid and Sulfapyridine on M. avium including Subspecies paratuberculosis
Robert J. Greenstein et al.
PLOS ONE (2007)
Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease
Warwick Selby et al.
GASTROENTEROLOGY (2007)
Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars
T. J. Borody et al.
DIGESTIVE AND LIVER DISEASE (2007)
Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis
Martin Feller et al.
LANCET INFECTIOUS DISEASES (2007)
A population-based ecologic study of inflammatory bowel disease: Searching for etiologic clues
Chris Green et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
High incidence of Crohn's disease in Canterbury, New Zealand: Results of an epidemiologic study
Richard B. Gearry et al.
INFLAMMATORY BOWEL DISEASES (2006)
Mycobacterium avium subsp paratuberculosis in the catchment area and water of the river Taff in South Wales, United Kingdom, an its potential relationship to clustering of Crohn's disease cases in the city of Cardiff
RW Pickup et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: A metaanalysis
M Economou et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease
J Hermon-Taylor
GUT (2001)